SERENELLI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 2.917
AS - Asia 1.879
EU - Europa 1.679
SA - Sud America 355
AF - Africa 37
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.870
Nazione #
US - Stati Uniti d'America 2.808
SG - Singapore 905
DE - Germania 574
CN - Cina 466
FI - Finlandia 298
BR - Brasile 297
IT - Italia 259
HK - Hong Kong 157
VN - Vietnam 133
GB - Regno Unito 125
PL - Polonia 122
SE - Svezia 56
CA - Canada 53
ID - Indonesia 53
FR - Francia 47
RU - Federazione Russa 47
MX - Messico 44
TR - Turchia 36
IN - India 35
UA - Ucraina 35
JP - Giappone 30
AR - Argentina 21
ES - Italia 21
BD - Bangladesh 20
NL - Olanda 20
BE - Belgio 16
ZA - Sudafrica 16
EC - Ecuador 15
AT - Austria 12
LT - Lituania 11
CH - Svizzera 9
CZ - Repubblica Ceca 9
IQ - Iraq 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
EG - Egitto 6
PK - Pakistan 5
PY - Paraguay 5
CL - Cile 4
IE - Irlanda 4
JO - Giordania 4
NI - Nicaragua 4
AZ - Azerbaigian 3
MA - Marocco 3
MY - Malesia 3
UY - Uruguay 3
UZ - Uzbekistan 3
CI - Costa d'Avorio 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
VE - Venezuela 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SV - El Salvador 1
Totale 6.870
Città #
Ashburn 490
Singapore 476
Munich 470
Fairfield 225
Helsinki 222
Beijing 186
Santa Clara 176
Hong Kong 157
Woodbridge 121
Warsaw 119
Chandler 110
Houston 109
New York 99
Ann Arbor 97
Seattle 97
Dallas 92
Los Angeles 89
Wilmington 77
Cambridge 72
Turku 48
Jakarta 46
Ho Chi Minh City 45
Milan 39
Shanghai 39
São Paulo 35
Princeton 33
Bremen 31
Jacksonville 31
London 31
Chicago 30
Orem 28
Tokyo 28
Ferrara 27
Mexico City 26
Denver 25
Hanoi 24
Izmir 23
Bologna 22
San Diego 21
Montreal 20
Poplar 20
Toronto 19
Brooklyn 17
Frankfurt am Main 17
Boston 16
Brussels 16
Stockholm 16
Moscow 15
Nuremberg 15
Atlanta 14
Jyväskylä 14
Nanjing 14
Salt Lake City 14
Chennai 13
Johannesburg 13
Hefei 12
Buffalo 11
Falls Church 11
Redondo Beach 11
Rio de Janeiro 11
Columbus 10
Phoenix 10
Tianjin 10
Ankara 9
Brasília 9
Charlotte 8
Querétaro 8
Quito 8
Redwood City 8
The Dalles 8
Washington 8
Belo Horizonte 7
Boardman 7
Haiphong 7
Manchester 7
Mumbai 7
San Francisco 7
Campinas 6
Dong Ket 6
Falkenstein 6
Hebei 6
Nanchang 6
Ottawa 6
Rome 6
Vienna 6
Amsterdam 5
Biên Hòa 5
Campo Grande 5
Council Bluffs 5
Da Nang 5
Guangzhou 5
Jinan 5
Lappeenranta 5
Shenyang 5
Amman 4
Assago 4
Augusta 4
Changsha 4
City of London 4
Curitiba 4
Totale 4.680
Nome #
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 375
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 336
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 327
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 255
Atrial Longitudinal Strain Predicts New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis 255
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 237
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 205
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 201
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 194
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 187
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 182
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 179
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 164
Direct oral anticoagulants for the treatment of left ventricular thrombosis: an updated systematic review and meta-analysis 163
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 159
Angina and chronic obstructive pulmonary disease: facing the perfect storm 156
Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study 154
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 152
The impact of the 3-year ABSORB II trial results on my clinical practice: An Italian survey 151
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 147
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 126
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge 120
Efficacy and safety of alternative oral administrations of P2Y12-receptor inhibitors: Systematic review and meta-analysis 119
Cardiopulmonary exercise testing predicts prognosis in amyloid cardiomyopathy: a systematic review and meta-analysis 117
Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes 113
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome 112
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 109
Drug-based cardiovascular prevention in patients with Marfan Syndrome: a systematic review 102
Standard ecg in brugada syndrome as a marker of prognosis: From risk stratification to pathophysiological insights 102
Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications 102
Clinical Outcome of FFR-Guided Revascularization Strategy of Coronary Lesions: The HALE-BOPP Study 102
The impact of sex and physical performance on long-term mortality in older patients with myocardial infarction 100
30-Day DAPT in Patients at High Bleeding Risk Undergoing PCI With Biodegradable-Polymer Sirolimus-Eluting Ultra-Thin Stent 97
Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index 94
Neurological involvement in Ile68Leu (p.Ile88Leu) ATTR amyloidosis: not only a cardiogenic mutation 92
The role of stress echocardiography in transcatheter aortic valve implantation and transcatheter edge-to-edge repair era: A systematic review 92
Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review 90
Impact of comorbidities on older patients undergoing open heart surgery 87
Diagnosis and treatment of cardiomyopathies: A paradigm shift and an evolutionary step forward in cardiology 82
Complete versus culprit-only strategy in older MI patients with multivessel disease 80
Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction 65
The left atrium in cardiac amyloidosis: a valuable but still underused observation window on the overall disease process 65
Impact of pre-admission physical activity on benefits of physiology-guided complete revascularization in older patients with myocardial infarction: insights from the FIRE trial 62
Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis 55
The impact of sex and physical performance on long-term mortality in older patients with myocardial infarction 52
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 49
Coronary Atherosclerosis Phenotypes in Non-Flow-Limiting Nonculprit Lesions of Older Patients With MI Stratified by Focal and Diffuse Disease Patterns 48
Total atrial conduction time predicts new-onset atrial fibrillation in patients with transthyretin amyloid cardiomyopathy 43
Echocardiographic index of left ventricular performance for prognostication in transthyretin cardiac amyloidosis: the central role of stroke volume index 40
T1 mapping and major cardiovascular events in non-ischaemic dilated cardiomyopathy: a systematic review and meta-analysis 35
Unexpected Clinically Relevant Findings Detected via Computed Tomography in Patients with Severe Aortic Stenosis Who Are Candidates for Transcatheter Aortic Valve Replacement 31
Analysis of Calcium Scores in Severe Aortic Stenosis Patients With and Without Cardiac Amyloidosis: The CAUSATIVE Study 29
Tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio in Hypertrophic cardiomyopathy 29
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy 25
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 24
An unusual bundle branch block 23
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 22
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis 21
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 20
Clinical Phenotype and Prognosis of Asymptomatic Patients with Transthyretin Cardiac Amyloid Infiltration 19
The treatment of amyloidosis is being refined 16
Cardiovascular prevention: sometimes dreams can come true 15
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 15
Reply: Mineralocorticoid Receptor Antagonists, Blood Pressure, and Drug Discontinuation 9
Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus Document. Edited by the Italian Cardiac Amyloidosis Network (RIAC) 7
Efficacy and Safety of Dapagliflozin in Heart Failure with Reduced Ejection Fraction According to Age: Insights from DAPA-HF 6
Temporal implementation of a regional referral pathway in transthyretin cardiac amyloidosis: Emilia-Romagna experience 5
Renal Function-Stratified Comparison of Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and Multivessel Disease 5
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 4
Early-stage amyloid transthyretin cardiomyopathy: uncertainties and opportunities 4
Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES 3
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis 3
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 3
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF) 2
Totale 7.071
Categoria #
all - tutte 35.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.848


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021256 0 0 0 0 0 26 23 61 18 49 47 32
2021/2022346 39 23 16 16 25 22 26 20 18 22 49 70
2022/2023343 32 18 24 19 63 36 29 34 47 4 23 14
2023/2024361 16 36 20 7 34 85 18 38 3 4 15 85
2024/20252.230 42 38 102 96 196 282 295 189 435 127 234 194
2025/20262.614 440 145 337 579 892 221 0 0 0 0 0 0
Totale 7.071